Avalon Investment & Advisory Glaukos Corp Transaction History

Avalon Investment & Advisory

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$63.59 - $78.71 $228,415 - $282,726	-3,592 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$50.75 - $80.54 $182,294 - $289,299	3,592 New	3,592 $282,000
Q4 2017 Feb 14, 2018	SELL	$24.5 - $36.01 $327,124 - $480,805	-13,352 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$31.26 - $42.03 $11,472 - $15,425	-367 Reduced 2.68%	13,352 $441,000
Q2 2017 Aug 14, 2017	BUY	N/A	13,719	13,719 $569,000

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

Stay updated on Avalon Investment & Advisory with notifications on news.